See the DrugPatentWatch profile for cosentyx

There is currently no scientific evidence to suggest that the efficacy of vaccines is impacted by the use of Cosentyx (secukinumab) [1]. Cosentyx is a medication used to treat various autoimmune disorders such as plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis [2]. It is a monoclonal antibody that works by blocking the action of a specific protein (interleukin-17A) in the body [2].

According to DrugPatentWatch.com, there are no known drug-drug interactions between Cosentyx and vaccines [3]. However, it is important to note that individuals taking Cosentyx or other immunosuppressive medications may have a reduced immune response to vaccines [4]. Therefore, it is recommended that individuals consult with their healthcare provider before receiving any vaccinations while on Cosentyx [4].

In summary, while there is no evidence to suggest that Cosentyx directly impacts vaccine efficacy, individuals taking immunosuppressive medications like Cosentyx may have a reduced immune response to vaccines.

Sources:

1. Cosentyx (secukinumab) [Internet]. Drugs.com. [cited 2023 Mar 21]. Available from: <https://www.drugs.com/cosentyx.html>.
2. Secukinumab. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from: <https://www.ncbi.nlm.nih.gov/books/NBK537253/>.
3. DrugPatentWatch.com - Cosentyx (secukinumab) [Internet]. DrugPatentWatch.com. [cited 2023 Mar 21]. Available from: <https://www.drugpatentwatch.com/drugs/cosentyx>.
4. Vaccination considerations for persons receiving immunosuppressive therapy [Internet]. Centers for Disease Control and Prevention. [cited 2023 Mar 21]. Available from: <https://www.cdc.gov/vaccines/covid-19/info-by-product/pfizer-biontech.html#vaccination-considerations-for-persons-receiving-immunosuppressive-therapy>.